miR-144-3p inhibits the proliferation, migration and angiogenesis of multiple myeloma cells by targeting myocyte enhancer factor 2A

Multiple myelomas (MM) are the second most common haematological malignancy, for which no curative treatments have been reported to date. MicroRNAs (miRNAs or miRs) have recently been shown to be involved in the proliferation of MM cells. However, the molecular mechanisms through which miRNAs regula...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Fei, Wang, Huihan, Ma, Huanxin, Zhong, Yuan, Liao, Aijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387096/
https://www.ncbi.nlm.nih.gov/pubmed/32705159
http://dx.doi.org/10.3892/ijmm.2020.4670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387096/
https://www.ncbi.nlm.nih.gov/pubmed/32705159
http://dx.doi.org/10.3892/ijmm.2020.4670

Ejemplares similares